Combined splenic fossa auxiliary partia1 heterotopic liver transplantation and kidney transplantation in highly sensitized recipients

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-ONC-14004649

Enrollment

Unknown

Registered

2014-02-17

Start date

2013-10-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

highly sensitized renal transplantation recipients

Interventions

auxiliary partial heterotopic liver transplantatio:Combined splenic fossa auxiliary partial heterotopic liver transplantation and kidney transplantation

Eligibility

Sex/Gender

Male

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Highly sensitized end stage renal desease patients. PRA(panel reactive antibody)>50%

Exclusion criteria

Exclusion criteria: Nonsensitized patients who are suitable for routine renal transplantation.

Design outcomes

Primary

Measure	Time frame
Hyperacute rejection;Serum creatinine;serum urea nitrogen;donor specific antibodie;	—

Countries

China

Contacts

Public ContactYUAN Jian-lin

jianliny@fmmu.edu.cn+86 13609123155

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026